NCT00672035View on ClinicalTrials.gov

Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy Study

PHASE2CompletedINTERVENTIONAL

Enrollment

406

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

July 31, 2008

Conditions

Traveler's Diarrhea

Interventions

BIOLOGICAL

Biological: heat-labile enterotoxin of E. coli (LT)

LT patch applied on either the deltoid or the lower back.

Trial Locations (5)

13045

Asthma and Allergy Associates PC, Cortland

45249

Radiant Research - Cincinnati, Cincinnati

48025

QUEST Research Institute, Bingham Farms

78229

Clinical Trials of Texas, San Antonio

95616

Solano Clinical Research, Davis

All Listed Sponsors

lead

Intercell USA, Inc.

INDUSTRY

NCT00672035 - Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy Study | Biotech Hunter | Biotech Hunter